3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
13
Motor Activity
5
Colorectal Neoplasms
5
Smoking Cessation
4
Neoplasms
4
Lung Neoplasms
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Smoking
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
Colonic Neoplasms
2
Behavior
2
Skin Cancer Prevention
1
Polycystic Ovary Syndrome
1
Patient Compliance
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Other Cancer
1
Obesity
1
Melanoma
1
Medication Adherence
1
Lymphedema
1
Gastrointestinal Neoplasms
1
Colorectal Cancer Screening
1
Chronic Pain
1
Body Weight Changes
1
Body Weight
1
Anxiety Disorders
1
Interventions
Oxaliplatin
29
Fluorouracil
25
Leucovorin
20
Capecitabine
18
Irinotecan
17
Bevacizumab
14
Cisplatin
12
Surveys and Questionnaires
11
Gemcitabine
9
Drug Therapy
9
Standard of Care
8
Nivolumab
7
Cetuximab
7
pembrolizumab
6
S 1 (combination)
6
Cyclophosphamide
6
atezolizumab
5
Specimen Handling
5
Endoscopic Mucosal Resection
5
Educational Status
5
Docetaxel
5
Blood Specimen Collection
5
fludarabine
4
aldesleukin
4
Radiotherapy
4
Radiosurgery
4
Pemetrexed
4
IFL protocol
4
Folfox protocol
4
Everolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Gastrointestinal Neoplasms
×
Motivational Interviewing
×
Clear all
NCT04899492
2024-11-07
RESPIRE
Institut Cancerologie de l'Ouest
Phase NA
Terminated
22 enrolled